215 related articles for article (PubMed ID: 17244250)
1. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.
Deuffic-Burban S; Poynard T; Sulkowski MS; Wong JB
J Viral Hepat; 2007 Feb; 14(2):107-15. PubMed ID: 17244250
[TBL] [Abstract][Full Text] [Related]
2. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
Sypsa V; Touloumi G; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Delladetsima J; Demonakou M; Hatzakis A
J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
[TBL] [Abstract][Full Text] [Related]
3. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections.
Deuffic-Burban S; Mohamed MK; Larouze B; Carrat F; Valleron AJ
J Hepatol; 2006 Mar; 44(3):455-61. PubMed ID: 16310281
[TBL] [Abstract][Full Text] [Related]
4. Projecting future complications of chronic hepatitis C in the United States.
Davis GL; Albright JE; Cook SF; Rosenberg DM
Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
[TBL] [Abstract][Full Text] [Related]
5. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.
Armstrong GL; Alter MJ; McQuillan GM; Margolis HS
Hepatology; 2000 Mar; 31(3):777-82. PubMed ID: 10706572
[TBL] [Abstract][Full Text] [Related]
6. Comparison of deaths related to Hepatitis C and AIDS in Scotland.
Palmateer NE; Hutchinson SJ; McLeod A; Codere G; Goldberg DJ
J Viral Hepat; 2007 Dec; 14(12):870-4. PubMed ID: 18070290
[TBL] [Abstract][Full Text] [Related]
7. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
[TBL] [Abstract][Full Text] [Related]
8. Modelling and calibration of the hepatitis C epidemic in Australia.
Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
[TBL] [Abstract][Full Text] [Related]
9. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
Lehman EM; Wilson ML
J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
[TBL] [Abstract][Full Text] [Related]
10. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
[TBL] [Abstract][Full Text] [Related]
11. Is there an epidemic of HIV Infection in the US ESRD program?
Eggers PW; Kimmel PL
J Am Soc Nephrol; 2004 Sep; 15(9):2477-85. PubMed ID: 15339998
[TBL] [Abstract][Full Text] [Related]
12. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus and human immunodeficiency virus co-infection in women.
Orenstein R; Tsogas N
J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 2):S1-6. PubMed ID: 11794748
[TBL] [Abstract][Full Text] [Related]
14. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).
Rosenthal E; Pialoux G; Bernard N; Pradier C; Rey D; Bentata M; Michelet C; Pol S; Perronne C; Cacoub P;
J Viral Hepat; 2007 Mar; 14(3):183-8. PubMed ID: 17305884
[TBL] [Abstract][Full Text] [Related]
15. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
16. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study.
Omland LH; Jepsen P; Skinhøj P; Jørgensen HL; Münster AM; Bangsborg J; Fenger M; Sørensen HT; Obel N
HIV Med; 2009 Feb; 10(2):65-71. PubMed ID: 19018878
[TBL] [Abstract][Full Text] [Related]
17. Understanding hepatitis C.
McHutchison JG
Am J Manag Care; 2004 Mar; 10(2 Suppl):S21-9. PubMed ID: 15084064
[TBL] [Abstract][Full Text] [Related]
18. Global burden of disease (GBD) for hepatitis C.
Global Burden Of Hepatitis C Working Group
J Clin Pharmacol; 2004 Jan; 44(1):20-9. PubMed ID: 14681338
[TBL] [Abstract][Full Text] [Related]
19. Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments.
Sypsa V; Touloumi G; Papatheodoridis GV; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Koutsounas S; Hatzakis A
J Viral Hepat; 2005 Sep; 12(5):543-50. PubMed ID: 16108772
[TBL] [Abstract][Full Text] [Related]
20. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
